Post-authorization, Observational and Prospective Follow up Study to Evaluate Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs.

Trial Profile

Post-authorization, Observational and Prospective Follow up Study to Evaluate Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs.

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 May 2013

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Acronyms ZAGAL
  • Sponsors Eisai Inc; Eisai Medical Research
  • Most Recent Events

    • 07 Aug 2009 Planned number of patients changed from 100 to 32 as reported by ClinicalTrials.gov.
    • 07 Aug 2009 Planned end date changed from 1 Jul 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.
    • 23 Jul 2008 Status changed from initiated to recruiting in progress as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top